JOHNSON & JOHNSON INVESTIGATION UPDATE by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Johnson & Johnson - JNJ

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Johnson & Johnson (J&J) (NYSE: JNJ).

Metadata
Provider: 
Business Wire, Inc.
Retrieved on: 
Saturday, August 17, 2019
Information
Tags: 
Legal, Professional services, Minerals, Health, Chemical substances, Excipients, Phyllosilicates, Talc, Johnson & Johnson, Charles Foti, Asbestos, Fiduciary, Foti
Geotags: 
LOUISIANA, United States
⚠generated by AI ↴
Summary
Key Points: 
  • Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Johnson & Johnson (J&J) (NYSE: JNJ).
  • The Company has been embroiled in significant litigation by over 11,000 consumers claiming that its iconic talc powder products contained asbestos that caused cancer.
  • On July 12, 2019, news sources reported that the Company was under investigation by the U.S. Justice Department regarding whether it lied about the possible cancer risks from its talcum powder.
  • KSFs investigation is focusing on whether J&Js officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.


Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Johnson & Johnson (“J&J”) (NYSE: JNJ).

The Company has been embroiled in significant litigation by over 11,000 consumers claiming that its iconic talc powder products contained asbestos that caused cancer. Some cases have resulted in massive verdicts against J&J including a $117 million award by one New Jersey jury in April 2018 and a $4.7 billion award in Missouri to 22 plaintiffs in July 2018. On July 12, 2019, news sources reported that the Company was under investigation by the U.S. Justice Department regarding whether it lied about the possible cancer risks from its talcum powder.

Recently, on July 29, 2019, the Company disclosed that it had received a civil investigative demand from the Federal Trade Commission relating to possible antitrust law violations by the Company in marketing its blockbuster rheumatoid arthritis drug, Remicade.

The Company has been exposed to significant financial losses as well as a securities class action lawsuit for failing to disclose material information to investors, violating federal securities laws, which is ongoing.

KSF’s investigation is focusing on whether J&J’s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of J&J shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-jnj/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Copyright: 
Copyright Business Wire 2019